-- Prolor Biotech Climbs Most in Two Weeks on Trial Update
-- B y   D a v i d   W a i n e r
-- 2012-05-07T13:50:09Z
-- http://www.bloomberg.com/news/2012-05-07/prolor-heads-for-biggest-gain-in-2-weeks-on-growth-hormone-trial.html
Prolor Biotech Inc. (PBTH)  gained the most in
two weeks after results from an extended Phase II trial of hGH-
CTP human growth hormone showed a single weekly treatment may
replace daily injections and was safe.  The  shares  jumped 3.8 percent, the most since April 22, to
20.89 shekels at the 4:30 p.m. close in  Tel Aviv .  To contact the reporter on this story:
David Wainer in Tel Aviv at 
 dwainer3@bloomberg.net   To contact the editor responsible for this story:
Claudia Maedler at 
 cmaedler@bloomberg.net  